| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/21/2004 | EP1438026A2 Taste masking spill-resistant formulation |
| 07/21/2004 | EP1438019A1 Kit for the preparation of a pharmaceutical composition |
| 07/21/2004 | EP1438018A1 Fondant-based pharmaceutical composition |
| 07/21/2004 | EP1437945A1 Use of cystathionine |
| 07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1223958A4 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 07/21/2004 | CN1514879A Moraxella (branhamella) catarrhalis antigens |
| 07/21/2004 | CN1514825A New compounds useful in reflux disease |
| 07/21/2004 | CN1514723A Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 07/21/2004 | CN1513844A New Carboxglic acid derivative, its preparation and application |
| 07/21/2004 | CN1513558A Anti irritability Specificity Igy and its preparation |
| 07/21/2004 | CN1513552A Lung tissue endochylema bacteria (Sacheromyces globosus) series vaccine and diagnoses agent and production method |
| 07/21/2004 | CN1513529A Pill for clearing heat and dispelling scourge |
| 07/21/2004 | CN1513518A Medicine for treating acute chronic bronchitis and its preparation method |
| 07/21/2004 | CN1513517A Medicine for treating wind warmth and lung heat pathocondition and its preparation method |
| 07/21/2004 | CN1513512A Nano-chinese medicine composition for treating primary bronchus lung cancer and its preparation method |
| 07/21/2004 | CN1513510A Chinese medicine compound preparation for treating acute pharyngolaryngitis and its preparation method |
| 07/21/2004 | CN1513508A Medicine composition for treating uppe respiration channel infetion and its preparing process |
| 07/21/2004 | CN1513505A Method for preparing qingkailing granules |
| 07/21/2004 | CN1513501A Jiedufeitai medicine for disintoxication and beneficial to lung |
| 07/21/2004 | CN1513480A Artificial bear gall |
| 07/21/2004 | CN1513475A Process for preparing buccal lozenge contg. compound sede-iodine |
| 07/21/2004 | CN1513455A prepn. for stopping vomitus contg. compound pentoxifylline |
| 07/21/2004 | CN1513446A Injection of sodium bouttuynin, and its prepn. method |
| 07/21/2004 | CN1513439A Slow release medicine of pseudo-ephedrine hydrochloride |
| 07/21/2004 | CN1513381A Solid prepn. with functions of clearing and moistening throat, and its prodn. technique |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158290C Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158266C Compounds |
| 07/21/2004 | CN1158265C Quinoline ketone derivant and antianaphylaction using same as active substance |
| 07/21/2004 | CN1158259C Potassium channel openers |
| 07/21/2004 | CN1158256C Pyrrolidine derivatives-CCR-3 receptor antagonists |
| 07/21/2004 | CN1158100C Medicine for nasal obstruction |
| 07/20/2004 | US6765095 2,3-disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6764534 Portable oxygen concentrator |
| 07/20/2004 | CA2408633C Management of snoring by oral administration of dimethyl sulfone |
| 07/20/2004 | CA2292388C Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 07/15/2004 | WO2004058969A1 Preventives/remedies for cancer |
| 07/15/2004 | WO2004058772A1 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same |
| 07/15/2004 | WO2004058742A1 Benzocycloheptapyridine compounds |
| 07/15/2004 | WO2004058736A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058731A1 Benzamide inhibitors of the p2x7 receptor |
| 07/15/2004 | WO2004058709A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058283A1 Development of an anti-cough, anti-tussive and throat soothing herbal formulation |
| 07/15/2004 | WO2004058236A1 Compositions and methods for treating upper respiratory congestion |
| 07/15/2004 | WO2004058233A1 Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate |
| 07/15/2004 | WO2004041865A3 Stabilized single domain antibodies |
| 07/15/2004 | WO2004041863A3 Single domain antibodies directed against interferon- gamma and uses therefor |
| 07/15/2004 | WO2004002535A8 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003099226A3 Antibody peg positional isomers, compositions comprising same, and use thereof |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003078579A3 Compositions and methods for treating emphysema |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | US20040138709 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 07/15/2004 | US20040138454 Drugs for treating pain formed by arylation |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138289 Quaternary ammonium compounds |
| 07/15/2004 | US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 07/15/2004 | US20040138276 Metalloproteinase inhibitors |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders |
| 07/15/2004 | US20040138259 Pain management |
| 07/15/2004 | US20040138253 Quaternary ammonium compounds |
| 07/15/2004 | US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries |
| 07/15/2004 | US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics |
| 07/15/2004 | US20040138186 3-Nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 07/15/2004 | US20040138143 Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137485 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1 |
| 07/15/2004 | US20040137074 Osteoprotegerin in milk |
| 07/15/2004 | US20040137006 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136996 anti-human interleukin-5 receptor alpha -chain monoclonal antibody; asthma; atopic dermatitis |
| 07/15/2004 | US20040136953 diagnosing aggressive form of respiratory condition by a different T helper cell response when samples are incubated with antigen characteristic of condition; treatment with interferon gamma |
| 07/15/2004 | US20040136920 aerosol formulation which comprises particulate salbutamol or a physiologically acceptable salt or solvate thereof and 1,1,1,2-tetrafluoroethane as propellant, which formulation is substantially free of surfactant |
| 07/15/2004 | US20040136918 salmeterol xinafoate and fluticasone propionate in a metered does inhaler with propellant |
| 07/15/2004 | US20040134487 Methods and devices for use in performing pulmonary procedures |
| 07/15/2004 | CA2511189A1 Benzamide inhibitors of the p2x7 receptor |
| 07/15/2004 | CA2510779A1 Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate |
| 07/15/2004 | CA2509501A1 Compositions and methods for treating upper respiratory congestion |
| 07/14/2004 | EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436381A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436323A1 Crystal structure of baff, and use thereof in drug design |
| 07/14/2004 | EP1436322A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 07/14/2004 | EP1436298A1 Himbacine analogues as thrombin receptor antagonists |
| 07/14/2004 | EP1436292A1 5-methoxy-8-aryl-[1,2,4]triazolo[1,5-a]pyridine derivatives as adenosine receptor antagonists |